Details for New Drug Application (NDA): 065187
✉ Email this page to a colleague
NDA 065187 describes NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN, which is a drug marketed by Bausch And Lomb, Ipharm, Nordic Pharma, and Watson Labs, and is included in four NDAs. It is available from two suppliers. Additional details are available on the NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN profile page.
The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN is gramicidin; neomycin sulfate; polymyxin b sulfate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the gramicidin; neomycin sulfate; polymyxin b sulfate profile page.
The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN is gramicidin; neomycin sulfate; polymyxin b sulfate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the gramicidin; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 065187
| Tradename: | NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN |
| Applicant: | Nordic Pharma |
| Ingredient: | gramicidin; neomycin sulfate; polymyxin b sulfate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML | ||||
| Approval Date: | Oct 28, 2005 | TE: | AT | RLD: | No | ||||
Complete Access Available with Subscription
